Log In
BCIQ
Print this Print this
 

ProParaflu+

  Manage Alerts
Collapse Summary General Information
Company Hologic Inc.
DescriptionReal-time reverse transcriptase-polymerase chain reaction (RT-PCR) to identify parainfluenza 1, 2 and 3 viruses from nasal swabs
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect and differentiate parainfluenza 1, 2 and 3 viruses
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today